EUVIMEDEUVIMED entdecken
Übersichtsarbeit

USP10 Dysregulation in Oncogenic Virus‐Driven Tumourigenesis and Immune Evasion

Zike Li, Dongjing Zhang, Siqi Chen, Xin Zhang, Zhihong Wang, Changsheng Huang, Qi Wu, Anyi Liu, Kangdi Li, Ziran Wei, Junbo Hu iD

Reviews in Medical Virology · 2026-05 · 36 (3)

DOI: 10.1002/rmv.70145 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reviews in Medical Virology, online erschienen am 16.04.2026. Verfasst von Zike Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: GI Cancer Research Institute, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Ubiquitin Thiolesterase, Immune Evasion, Oncogenic Viruses, Host-Pathogen Interactions. Die Arbeit nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ubiquitination is a critical post‐translational modification that regulates protein stability, signalling pathways, and cellular homoeostasis. Increasing evidence shows that oncogenic viruses exploit the host ubiquitin system to promote viral persistence, immune evasion, and malignant transformation. Among the various host factors targeted, deubiquitinating enzymes (DUBs) play a pivotal role because they reverse ubiquitination, thereby regulating the stability, localization, and activity of key signalling proteins. Ubiquitin‐specific peptidase 10 (USP10) has emerged as a particularly critical DUB in the context of viral tumourigenesis, functioning as a molecular rheostat that balances tumour suppression and oncogenic progression. The dysregulation of USP10 by viral oncoproteins facilitates a dual assault on the host: the subversion of innate immune sensors, specifically the RIG‐I, MAVS, and cGAS‐STING pathways, and the evasion of adaptive immune surveillance through the stabilisation of immune checkpoints, such as PD‐L1, and the disruption of MHC‐I antigen presentation. This comprehensive analysis explores the biochemical architecture of USP10, its paradoxical roles in cancer, and the specific mechanisms through which oncogenic viruses exploit this enzyme to drive malignancy and immune escape.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin ThiolesteraseImmune EvasionOncogenic VirusesHost-Pathogen InteractionsNeoplasmsCarcinogenesisHumansAnimalsSignal TransductionUbiquitination

Stichwörter der Autor:innen

USP10oncovirusestumourigenesisubiquitination

Substanzen

Ubiquitin ThiolesteraseUSP10 protein, human

Autor:innen und Institutionen

  • GI Cancer Research Institute, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Gastrointestinal Surgery, Second Affiliated Hospital of Naval Medical University, Shanghai, China.

ORCID-Profile: Junbo Hu

Zitieren

APA

Li, Z., Zhang, D., Chen, S., Zhang, X., Wang, Z., Huang, C., Wu, Q., Liu, A., Li, K., Wei, Z., & Hu, J. (2026). USP10 Dysregulation in Oncogenic Virus‐Driven Tumourigenesis and Immune Evasion. Reviews in Medical Virology, 36(3). https://doi.org/10.1002/rmv.70145

Vancouver

Li Z, Zhang D, Chen S, Zhang X, Wang Z, Huang C, et al. USP10 Dysregulation in Oncogenic Virus‐Driven Tumourigenesis and Immune Evasion. Reviews in Medical Virology. 2026;36(3). doi:10.1002/rmv.70145

BibTeX
@article{Li2026,
  author = {Li, Zike and Zhang, Dongjing and Chen, Siqi and Zhang, Xin and Wang, Zhihong and Huang, Changsheng and Wu, Qi and Liu, Anyi and Li, Kangdi and Wei, Ziran and Hu, Junbo},
  title = {USP10 Dysregulation in Oncogenic Virus‐Driven Tumourigenesis and Immune Evasion},
  journal = {Reviews in Medical Virology},
  year = {2026},
  volume = {36},
  number = {3},
  doi = {10.1002/rmv.70145}
}
Kostenlos starten →